A global review and perspective on prostate cancer survival: findings from survival studies of cancer registration data
Journal of the National Cancer Center · 2026-04 · 6 (2) · 175-184
DOI: 10.1016/j.jncc.2026.01.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the National Cancer Center, 2026-04. Verfasst von Yuxin Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology & State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong Unive…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Background
To better understand global status, temporal trends, and geographic disparities of prostate cancer survival, we systematically collected published survival studies on prostate cancer from cancer registries worldwide.
Methods
A comprehensive literature search was conducted in databases such as PubMed, Embase, Web of Science, SinoMed, CNKI and SEER for survival studies from cancer registries up to April 30, 2025. We synthesized data on observed, relative and net survival since the 1990s, along with age-standardized survival, and further stratified based on age at diagnosis and stage.
Results
The overall survival was favorable and exhibited a continuous improving trend. In most countries and regions, the 5-year relative survival rate exceeded 70%. However, substantial geographic disparities were observed. The prognosis was better in developed countries in Europe and America than that in less developed countries in Asia and Africa. Since 2000, the age-standardized 5-year relative survival was the highest in the United States at 98.5% (2007-2010), while it was the lowest in Punjab of India at 30.3% (2013-2016). The prognosis was poorest for patients aged ≥ 75, or for those diagnosed with distant or stage IV.
Conclusions
Although the survival has been improving over the past three decades, disparities between developed and less developed countries still persist. The extent of the popularization of prostate screening programs, the age or stage at diagnosis, and the sophistication of healthcare systems are likely to be significant contributing factors to these differences. Our results can provide fundamental statistics for formulating and refining relevant policies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology & State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- School of Public Health, Fudan University, Shanghai, China.
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Zhou, Y., Zou, Y., Shen, Q., Li, Z., Tan, Y., Li, H., & Xiang, Y. (2026). A global review and perspective on prostate cancer survival: findings from survival studies of cancer registration data. Journal of the National Cancer Center, 6(2), 175-184. https://doi.org/10.1016/j.jncc.2026.01.005
Vancouver
Zhou Y, Zou Y, Shen Q, Li Z, Tan Y, Li H, et al. A global review and perspective on prostate cancer survival: findings from survival studies of cancer registration data. Journal of the National Cancer Center. 2026;6(2):175-184. doi:10.1016/j.jncc.2026.01.005
BibTeX
@article{Zhou2026,
author = {Zhou, Yuxin and Zou, Yixin and Shen, Qiuming and Li, Zhuoying and Tan, Yuting and Li, Honglan and Xiang, Yongbing},
title = {A global review and perspective on prostate cancer survival: findings from survival studies of cancer registration data},
journal = {Journal of the National Cancer Center},
year = {2026},
volume = {6},
number = {2},
pages = {175--184},
doi = {10.1016/j.jncc.2026.01.005}
}
EUVIMED